Italy has one of the best healthcare services in the world and is ranked among the leading pharmaceutical centres in the world, with double-digit growth for R&D investments. The life science industry is highly prioritised on the political agenda and incentive schemes of grants and soft loans are made accessible for foreign companies wanting to invest in Italy. With a total turnover of 779 million euro and employing more than 1689 people in 2022, the Danish Life Science industry has been operating successfully for years.

This export promotion is an opportunity for Danish companies to be a part of a Danish-Italian institutional symposium in strengthening health diplomacy and cross-border collaborations. Gain insights into the Italian healthcare challenges and promote your innovative Danish solutions to high-level Italian NHS decision makers and healthcare authorities.

Read more here.